These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30756134)

  • 21. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
    Berk M; Dean O; Cotton SM; Gama CS; Kapczinski F; Fernandes BS; Kohlmann K; Jeavons S; Hewitt K; Allwang C; Cobb H; Bush AI; Schapkaitz I; Dodd S; Malhi GS
    J Affect Disord; 2011 Dec; 135(1-3):389-94. PubMed ID: 21719110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations.
    Sarris J; Lake J; Hoenders R
    J Altern Complement Med; 2011 Oct; 17(10):881-90. PubMed ID: 22010777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment implications of predominant polarity and the polarity index: a comprehensive review.
    Carvalho AF; Quevedo J; McIntyre RS; Soeiro-de-Souza MG; Fountoulakis KN; Berk M; Hyphantis TN; Vieta E
    Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25522415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology.
    Gottlieb JF; Benedetti F; Geoffroy PA; Henriksen TEG; Lam RW; Murray G; Phelps J; Sit D; Swartz HA; Crowe M; Etain B; Frank E; Goel N; Haarman BCM; Inder M; Kallestad H; Jae Kim S; Martiny K; Meesters Y; Porter R; Riemersma-van der Lek RF; Ritter PS; Schulte PFJ; Scott J; Wu JC; Yu X; Chen S
    Bipolar Disord; 2019 Dec; 21(8):741-773. PubMed ID: 31609530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications.
    Rosenblat JD; McIntyre RS
    Brain Sci; 2017 Oct; 7(11):. PubMed ID: 29084144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of depressive and bipolar disorder patients with mixed features.
    Tondo L; Vázquez GH; Pinna M; Vaccotto PA; Baldessarini RJ
    Acta Psychiatr Scand; 2018 Sep; 138(3):243-252. PubMed ID: 29862493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bipolar disorder: how far are we from a rigorous definition and effective management?
    Emilien G; Septien L; Brisard C; Corruble E; Bourin M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):975-96. PubMed ID: 17459551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
    Geoffroy PA; Bellivier F; Henry C
    Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological agents under research for the maintenance treatment in bipolar disorder.
    Dimitrakopoulos S; Konstantakopoulos G
    Psychiatriki; 2015; 26(3):169-80. PubMed ID: 26480221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does recent mania affect response to antidepressants in bipolar disorder? A re-analysis of STEP-BD data.
    Mousavi Z; Johnson S; Li D
    J Affect Disord; 2018 Aug; 236():136-139. PubMed ID: 29734096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical studies on the use of lamotrigine in bipolar disorder.
    Calabrese JR; Rapport DJ; Shelton MD; Kujawa M; Kimmel SE
    Neuropsychobiology; 1998 Oct; 38(3):185-91. PubMed ID: 9778607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
    Goldberg JF; Perlis RH; Ghaemi SN; Calabrese JR; Bowden CL; Wisniewski S; Miklowitz DJ; Sachs GS; Thase ME
    Am J Psychiatry; 2007 Sep; 164(9):1348-55. PubMed ID: 17728419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?
    Soczynska JK; Kennedy SH; Goldstein BI; Lachowski A; Woldeyohannes HO; McIntyre RS
    Neurotoxicology; 2009 Jul; 30(4):497-521. PubMed ID: 19477018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.
    Sidor MM; Macqueen GM
    J Clin Psychiatry; 2011 Feb; 72(2):156-67. PubMed ID: 21034686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bipolar postpartum depression: An update and recommendations.
    Sharma V; Doobay M; Baczynski C
    J Affect Disord; 2017 Sep; 219():105-111. PubMed ID: 28535448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder.
    Köhler-Forsberg O; Sylvia L; Thase M; Calabrese JR; Deckersbach T; Tohen M; Bowden CL; McInnis M; Kocsis JH; Friedman ES; Ketter TA; McElroy S; Shelton RC; Nierenberg AA
    Depress Anxiety; 2017 Mar; 34(3):281-290. PubMed ID: 28135023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder.
    Maes M; Carvalho AF
    Mol Neurobiol; 2018 Dec; 55(12):8885-8903. PubMed ID: 29611101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Celecoxib Adjunct Treatment on Bipolar Disorder: Systematic Review and Meta-Analysis.
    Bavaresco DV; Colonetti T; Grande AJ; Colom F; Valvassori SS; Quevedo J; da Rosa MI
    CNS Neurol Disord Drug Targets; 2019; 18(1):19-28. PubMed ID: 30398124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.